{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:11:12Z","timestamp":1783379472081,"version":"3.54.6"},"reference-count":50,"publisher":"Informa UK Limited","issue":"4","funder":[{"name":"The Scientific Research Projects Coordination Unit of Istanbul University","award":["TSG-2018-27798"],"award-info":[{"award-number":["TSG-2018-27798"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.4155\/fmc-2023-0179","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T09:22:17Z","timestamp":1706606537000},"page":"295-310","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Novel 2-Indolinone Derivatives as Promising Agents against Respiratory Syncytial and Yellow Fever Viruses"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6703-9389","authenticated-orcid":false,"given":"\u00c7a\u011fla Beg\u00fcm","family":"Apayd\u0131n","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34126, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2412-2232","authenticated-orcid":false,"given":"F\u00fcsun","family":"G\u00f6kta\u015f","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34126, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9742-9302","authenticated-orcid":false,"given":"Lieve","family":"Naesens","sequence":"additional","affiliation":[{"name":"Rega Institute, KU Leuven, Department of Microbiology, Immunology &amp; Transplantation, B-3000, Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6916-122X","authenticated-orcid":false,"given":"Nilg\u00fcn","family":"Karal\u0131","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34126, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"e_1_3_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12098"},{"key":"e_1_3_7_4_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00102-15"},{"key":"e_1_3_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2014.01.040"},{"key":"e_1_3_7_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/vim.2019.0107"},{"issue":"3","key":"e_1_3_7_7_1","first-page":"270","article-title":"Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis","volume":"6","author":"Shearer FM","year":"2018","unstructured":"Shearer FM , Longbottom J , Browne AJ et al. Existing and potential infection risk zones of yellow fever worldwide: a modelling analysis. Lancet 6(3), 270\u2013278 (2018).","journal-title":"Lancet"},{"key":"e_1_3_7_8_1","unstructured":"WHO . Yellow fever. www.who.int\/news-room\/fact-sheets\/detail\/yellow-fever"},{"key":"e_1_3_7_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(01)00016-0"},{"key":"e_1_3_7_10_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03368-14"},{"key":"e_1_3_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2021.105180"},{"key":"e_1_3_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31450-2"},{"key":"e_1_3_7_13_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.00581"},{"key":"e_1_3_7_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25717"},{"key":"e_1_3_7_15_1","first-page":"5","article-title":"A review on Zika virus outbreak, epidemiology, transmission and infection dynamics","volume":"27","author":"Kazmi SS","year":"2020","unstructured":"Kazmi SS , Ali W , Bibi N , Nouroz F . A review on Zika virus outbreak, epidemiology, transmission and infection dynamics. J. Biol. Res. 27, 5 (2020).","journal-title":"J. Biol. Res."},{"key":"e_1_3_7_16_1","doi-asserted-by":"crossref","first-page":"e0229847","DOI":"10.1371\/journal.pone.0229847","article-title":"First report of Aedes albopictus infected by dengue and Zika virus in a rural outbreak in Brazil","volume":"15","author":"Rezende HR","year":"2020","unstructured":"Rezende HR , Romano CM , Claro IM et al. First report of Aedes albopictus infected by dengue and Zika virus in a rural outbreak in Brazil. PLOS ONE 15, e0229847 (2020).","journal-title":"PLOS ONE"},{"key":"e_1_3_7_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43651-3"},{"key":"e_1_3_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix968"},{"key":"e_1_3_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2022.105354"},{"key":"e_1_3_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(22)00291-2"},{"key":"e_1_3_7_21_1","first-page":"1","article-title":"RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Manuel O","year":"2019","unstructured":"Manuel O , Estabrook M . RNA respiratory viral infections in solid organ transplant recipients: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Transpl. Infect. Dis. 33, 1\u201310 (2019).","journal-title":"Transpl. Infect. Dis."},{"key":"e_1_3_7_22_1","first-page":"1","article-title":"Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion","volume":"95","author":"Interactions V","year":"2021","unstructured":"Interactions V , Tang W , Li Y et al. Mechanism of cross-resistance to fusion inhibitors conferred by the K394R mutation in respiratory syncytial virus fusion. J. Virol. 95, 1\u201317 (2021).","journal-title":"J. Virol."},{"key":"e_1_3_7_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2108903"},{"key":"e_1_3_7_24_1","first-page":"S66","article-title":"Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study","volume":"1","author":"Devincenzo J","year":"2014","unstructured":"Devincenzo J , Fathi H , McClure M et al. Treatment with oral ALS-008176, a nucleoside analog, rapidly reduces RSV viral load and clinical disease severity in a healthy volunteer challenge study. Infect. Dis. 1, S66\u2013S69 (2014).","journal-title":"Infect. Dis."},{"key":"e_1_3_7_25_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj5508"},{"key":"e_1_3_7_26_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01568"},{"key":"e_1_3_7_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/1389557518666180424093305"},{"key":"e_1_3_7_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2020.128900"},{"key":"e_1_3_7_29_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15030272"},{"key":"e_1_3_7_30_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050536"},{"key":"e_1_3_7_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-021-02832-4"},{"key":"e_1_3_7_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2007.02.016"},{"key":"e_1_3_7_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(02)00197-3"},{"key":"e_1_3_7_34_1","first-page":"3045","article-title":"Combinatorial optimization of isatin-\u03b2-thiosemicarbazones as anti-poxvirus agents","volume":"7","author":"Pirrung MC","year":"2005","unstructured":"Pirrung MC , Pansare SV , Das Sarma K et al. Combinatorial optimization of isatin-\u03b2-thiosemicarbazones as anti-poxvirus agents. Comb. Chem. 7, 3045\u20133050 (2005).","journal-title":"Comb. Chem."},{"key":"e_1_3_7_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2011.02.037"},{"key":"e_1_3_7_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.104202"},{"key":"e_1_3_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(94)90077-9"},{"key":"e_1_3_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2005.07.046"},{"key":"e_1_3_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0987(01)00197-X"},{"key":"e_1_3_7_40_1","first-page":"565","article-title":"Aminopyimidinimo isatin analogues: design of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broadspectrum chemotherapeutic properties","volume":"8","author":"Sriram D","year":"2005","unstructured":"Sriram D , Ratan Bal T , Yogeeswari P . Aminopyimidinimo isatin analogues: design of novel non-nucleoside HIV-1 reverse transcriptase inhibitors with broadspectrum chemotherapeutic properties. J. Pharm. Pharm. Sci. 8, 565\u2013577 (2005).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"e_1_3_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2005.07.006"},{"key":"e_1_3_7_42_1","first-page":"109","article-title":"Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives","volume":"1","author":"Terzio\u01e7lu N","year":"2006","unstructured":"Terzio\u01e7lu N , Karali N , G\u00fcrsoy A et al. Synthesis and primary antiviral activity evaluation of 3-hydrazono-5-nitro-2-indolinone derivatives. Arkivoc 1, 109\u2013118 (2006).","journal-title":"Arkivoc"},{"key":"e_1_3_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00706-013-1034-3"},{"key":"e_1_3_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2003.12.072"},{"key":"e_1_3_7_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.05.102"},{"key":"e_1_3_7_46_1","doi-asserted-by":"publisher","DOI":"10.1039\/D1NJ04816C"},{"key":"e_1_3_7_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02349-20"},{"key":"e_1_3_7_48_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906-021-03386-z"},{"key":"e_1_3_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.113767"},{"key":"e_1_3_7_50_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2021-0018"},{"key":"e_1_3_7_51_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc-2022-0139"},{"key":"e_1_3_7_52_1","doi-asserted-by":"publisher","DOI":"10.1099\/jgv.0.001235"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc-2023-0179","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T14:35:30Z","timestamp":1725374130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc-2023-0179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.4155\/fmc-2023-0179"],"URL":"https:\/\/doi.org\/10.4155\/fmc-2023-0179","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifmc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-06-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}